UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 143

Sortiert nach

Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration

Nature communications, 2017-10, Vol.8 (1), p.793-15, Article 793

2017

Volltextzugriff (PDF)

Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166

Nature communications, 2020-03, Vol.11 (1), p.1457-1457, Article 1457

2020

Volltextzugriff (PDF)

Correlation between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated with a MAGE Antigen

Proceedings of the National Academy of Sciences - PNAS, 2004-10, Vol.101 (Suppl 2), p.14631-14638

2004

Volltextzugriff (PDF)

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions

Cancer Immunology, Immunotherapy, 2019-04, Vol.68 (4), p.631-644

2019

Volltextzugriff (PDF)

Processing and presentation of tumor antigens and vaccination strategies

Current Opinion in Immunology, 2006-02, Vol.18 (1), p.98-104

2006

Volltextzugriff (PDF)

Human T cell responses against melanoma

Annual Review of Immunology, 2006-01, Vol.24 (1), p.175-208

2006

Volltextzugriff (PDF)

Extracellular galectins as controllers of cytokines in hematological cancer

Blood, 2018-08, Vol.132 (5), p.484-491

2018

Volltextzugriff (PDF)

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer

Journal of clinical medicine, 2021-06, Vol.10 (13), p.2872

2021

Volltextzugriff (PDF)

A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion

Nature communications, 2016-07, Vol.7 (1), p.12242-12242, Article 12242

2016

Volltextzugriff (PDF)

A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice

Cancer research (Chicago, Ill.), 2010-10, Vol.70 (19), p.7476-7488

2010

Volltextzugriff (PDF)

Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules

The Journal of immunology (1950), 2016-02, Vol.196 (4), p.1711-1720

2016

Volltextzugriff (PDF)

IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression

Cell reports (Cambridge), 2024-07, Vol.43 (7), p.114401, Article 114401

2024

Volltextzugriff (PDF)

Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients

Clinical cancer research, 2009-05, Vol.15 (10), p.3366-3375

2009

Volltextzugriff (PDF)

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

PloS one, 2012-10, Vol.7 (10), p.e46928-e46928

2012

Volltextzugriff (PDF)

Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations in N- and O-Glycosylation

The Journal of biological chemistry, 2012-03, Vol.287 (14), p.11240-11251

2012

Volltextzugriff (PDF)

An Antigenic Peptide Produced by Peptide Splicing in the Proteasome

Science (American Association for the Advancement of Science), 2004-04, Vol.304 (5670), p.587-590

2004

Volltextzugriff (PDF)

HELIOS-expressing human CD8 T cells exhibit limited effector functions

Frontiers in immunology, 2023, Vol.14, p.1308539-1308539

2023

Volltextzugriff (PDF)

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

The Journal of immunology (1950), 2004-06, Vol.172 (11), p.6649-6657

2004

Volltextzugriff (PDF)

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Journal of clinical oncology, 2005-12, Vol.23 (35), p.9008-9021

2005

Volltextzugriff (PDF)

Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

Cancers, 2021-03, Vol.13 (6), p.1362

2021

Volltextzugriff (PDF)

Comparison of stable human Treg and Th clones by transcriptional profiling

European journal of immunology, 2009-03, Vol.39 (3), p.869-882

2009

Volltextzugriff (PDF)

Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B‐fragment of Shiga toxin

European journal of immunology, 1998-09, Vol.28 (9), p.2726-2737

1998

Volltextzugriff (PDF)

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

The journal of gene medicine, 2003-08, Vol.5 (8), p.654-667

2003

Volltextzugriff (PDF)

T-cell responses of vaccinated cancer patients

Current opinion in immunology, 2003-04, Vol.15 (2), p.131-137

2003

Volltextzugriff (PDF)

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

Nature reviews. Cancer, 2014-02, Vol.14 (2), p.135

2014

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(143)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(100)
Humans
(99)
Immunology
(57)
Antigens, Neoplasm - Immunology
(52)
T-Lymphocytes, Cytotoxic - Immunology
(46)
Animals
(42)
Melanoma - Immunology
(40)
Antigens, Neoplasm - Genetics
(38)
Amino Acid Sequence
(35)
Neoplasm Proteins - Immunology
(35)
Oncology
(35)
Molecular Sequence Data
(34)
Biological And Medical Sciences
(28)
Medical Sciences
(26)
Antigen Presentation
(24)
Tumors
(24)
Cd4-Positive T-Lymphocytes - Immunology
(21)
Dendritic Cells - Immunology
(20)
Female
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration

Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166

Correlation between Tumor Regression and T Cell Responses in Melanoma Patients Vaccinated with a MAGE Antigen

How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions

Processing and presentation of tumor antigens and vaccination strategies

Human T cell responses against melanoma

Extracellular galectins as controllers of cytokines in hematological cancer

MDSC in Mice and Men: Mechanisms of Immunosuppression in Cancer

A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion

A Galectin-3 Ligand Corrects the Impaired Function of Human CD4 and CD8 Tumor-Infiltrating Lymphocytes and Favors Tumor Rejection in Mice

Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules

IRF4 impedes human CD8 T cell function and promotes cell proliferation and PD-1 expression

Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients

IRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastoma

Loss of Effector Function of Human Cytolytic T Lymphocytes Is Accompanied by Major Alterations in N- and O-Glycosylation

An Antigenic Peptide Produced by Peptide Splicing in the Proteasome

HELIOS-expressing human CD8 T cells exhibit limited effector functions

Messenger RNA-Electroporated Dendritic Cells Presenting MAGE-A3 Simultaneously in HLA Class I and Class II Molecules

Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells

Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma

Comparison of stable human Treg and Th clones by transcriptional profiling

Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B‐fragment of Shiga toxin

Lentivirally transduced dendritic cells as a tool for cancer immunotherapy

T-cell responses of vaccinated cancer patients

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

Suchergebnisse filtern